Indication

Metastatic breast carcinoma

Metastatic breast carcinoma, also designated as stage IV breast cancer, is an advanced malignancy originating from epithelial tissues within the breast ducts or lobules that has disseminated beyond local and regional lymphatics. Read more about Metastatic breast carcinoma

244 drugs 124 manufacturers

Advertisement

Drugs that treat it

Common Metastatic breast carcinoma therapies.

Showing 1–9 of 244 drugs

DOCETAXEL

METASTATIC BREAST CARCINOMA·+5
HOSPIRA
Filter & compare in the drug finder →Opens the drug finder with Metastatic breast carcinoma preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Metastatic breast carcinoma.

Metastatic breast carcinoma, also designated as stage IV breast cancer, is an advanced malignancy originating from epithelial tissues within the breast ducts or lobules that has disseminated beyond local and regional lymphatics.

Dissemination occurs when neoplastic mammary epithelial cells invade the bloodstream or lymphatic vessels and establish secondary lesions in distant anatomical sites, most commonly the skeletal system, liver, lungs, brain, and distant lymph nodes.

Primarily affecting adult females but also occurring rarely in males, the condition is clinically categorized by specific molecular biomarkers—including estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 (HER2) status—which govern disease kinetics, distant organ tropism, and systemic therapeutic responsiveness.

Personalize your experience

Follow Metastatic breast carcinoma and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it